Healthway Compounding Pharmacy   Report issue

For profit Phase 2
Founded: Saginaw MI United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2018
NCT03582722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Healthway Compounding Pharmacy in central Michigan

Active Ingredients

Drugs in Phase 2 Trials (1)

orlistat (xenical) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Poisoning (Phase 2)

Weight Loss (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1